Stay updated with breaking news from Coverage Determination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MOULTRIE, Ga. — Alzheimer’s disease and other dementias are devastating. On Jan. 6, the U.S. Food and Drug Administration approved a medication that offers hope to those with Alzheimer's.
The bill would have mandated insurance coverage for biomarker tests supported by medical and scientific evidence but not the prices that insurers would have to pay.
The Freedom of Information Act (FOIA) request seeks materials regarding cost considerations, the FDA’s Accelerated Approval Program, and potential harm to...
This Week in Washington: President Biden Reiterates Healthcare Priorities and Announces Initiatives in his State of the Union Address...
This Week in Washington: Continuing Resolution Moves Forward and Senate Sets Up Vote on FDA Commissioner Nomination this Week...